Perkinelmer LHS-AL25 ACULED Lens System

PERKINELMER’S NEW ACULEDTM LENS SYSTEM, LHS-AL25, INCREASES LIGHT INTENSITY FOR SPECIALTY LIGHTING APPLICATIONS

ACULED System Provides High Brightness and Brilliant Color Mixing

Pfaffenhofen, Germany — PerkinElmer Optoelectronics, a global technology leader in digital imaging, specialty lighting and optical detection technologies, today announced the availability of the ACULED LHS-AL25 (All Color Ultrabright LED Lens Holder System), an easily attachable, cost-effective lens collection system for use in a variety of specialty lighting applications including mood lighting, vision systems, architectural lighting, and medical lighting.

The ACULED LHS-AL25 system has a compact size with a surface area of 25×25 mm² and is available with two different lens apertures. The LHS-AL25-L22 lens has a medium aperture of 22&#186 which can be used to make the ACULED a highlighter for illumination applications such as color changing spotlights. The LHS-AL25-L32 has a wider aperture of approximately 32&#186 and can be used to create a light cone for small distances between the ACULED and illuminated object. Both lens types provide superior far field color mixing for distances of over 20 cm from the lens.

The ACULED LHS-AL25 is very competitively priced. An evaluation kit is available with the ACULED, along with the two new lens models and may be ordered through our Customer Support centers in Europe and North America.

PerkinElmer Optoelectronics is a global technology leader in digital imaging, specialty lighting and optical detection technologies. We provide applications-driven, integrated solutions to leading OEMs in Health Sciences and Industrial Science markets. More information about PerkinElmer Optoelectronics recent announcements is available at http://optoelectronics.perkinelmer.com/content/corporate/news/pressreleases.aspx.

Factors Affecting Future Performance
This press release contains “forward-looking” statements within the meaning of the Private Securities Litigation Reform Act of 1995, including, but not limited to, statements relating to estimates and projections of future earnings per share and revenue growth and other financial results, developments relating to our customers and end-markets, and plans concerning business development opportunities. Words such as “believes,” “intends,” “anticipates,” “plans,” “expects,” “projects,” “forecasts,” “will” and similar expressions, and references to guidance, are intended to identify forward-looking statements. Such statements are based on management’s current assumptions and expectations and no assurances can be given that our assumptions or expectations will prove to be correct. A number of important risk factors could cause actual results to differ materially from the results described, implied or projected in any forward-looking statements. These factors include, without limitation: (1) our failure to introduce new products in a timely manner; (2) our ability to execute acquisitions and license technologies, or to successfully integrate acquired businesses and licensed technologies into our existing business or to make them profitable; (3) our failure to protect adequately our intellectual property; (4) the loss of any of our licenses or licensed rights; (5) our ability to compete effectively; (6) fluctuation in our quarterly operating results and our ability to adjust our operations to address unexpected changes; (7) our ability to produce an adequate quantity of products to meet our customers’ demands; (8) our failure to maintain compliance with applicable government regulations; (9) regulatory changes; (10) economic, political and other risks associated with foreign operations; (11) our ability to retain key personnel; (12) restrictions in our credit agreement; (13) our ability to realize the full value of our intangible assets; and (14) other factors which we describe under the caption “Risk Factors” in our most recent annual report on Form 10-K and in our most recent quarterly report on Form 10-Q and in our other filings with the Securities and Exchange Commission. We disclaim any intention or obligation to update any forward-looking statements as a result of developments occurring after the date of this press release.

PerkinElmer, Inc. is a global technology leader driving growth and innovation in Health Sciences and Photonics markets to improve the quality of life. The Company reported revenues of $1.5 billion in 2005, has 8,000 employees serving customers in more than 125 countries, and is a component of the S&P 500 Index. Additional information is available through www.perkinelmer.com or 1-877-PKI-NYSE.
###